Cita APA (7a ed.)
Villalobos, A., Dabbous, H. H., Little, O., Gbolahan, O. B., Akce, M., Lilly, M. A., . . . Kokabi, N. (2023). Safety and Efficacy of Concurrent Atezolizumab/Bevacizumab or Nivolumab Combination Therapy with Yttrium-90 Radioembolization of Advanced Unresectable Hepatocellular Carcinoma. Current Oncology, 30(12), 10100-10111.
Cita Chicago Style (17a ed.)
Villalobos, Alexander, Howard Hussein Dabbous, Olivia Little, Olumide Babajide Gbolahan, Mehmet Akce, Meghan Allegra Lilly, Zachary Bercu, y Nima Kokabi. "Safety and Efficacy of Concurrent Atezolizumab/Bevacizumab or Nivolumab Combination Therapy with Yttrium-90 Radioembolization of Advanced Unresectable Hepatocellular Carcinoma." Current Oncology 30, no. 12 (2023): 10100-10111.
Cita MLA (9a ed.)
Villalobos, Alexander, et al. "Safety and Efficacy of Concurrent Atezolizumab/Bevacizumab or Nivolumab Combination Therapy with Yttrium-90 Radioembolization of Advanced Unresectable Hepatocellular Carcinoma." Current Oncology, vol. 30, no. 12, 2023, pp. 10100-10111.
Precaución: Estas citas no son 100% exactas.